Clinical Trial Update: Concurrent Intrathecal-pemetrexed and Involved-field Radiotherapy for Leptomeningeal Metastasis From Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating concurrent intrathecal pemetrexed with involved-field radiotherapy for leptomeningeal metastasis from solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leptomeningeal Metastasis

Drugs mentioned

• Pemetrexed (intrathecal) (pemetrexed)

Snippet

Sponsor: The First Hospital of Jilin University | Conditions: Leptomeningeal Metastasis | Phase 1, Phase 2 | Status: COMPLETED